TMCI — TREACE MEDICAL CONCEPTS, INC.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1630627 ·
Last close
$4.06
Market Cap
$263.38M
52W High
$4.47
52W Low
$1.17
ADV30
624,697
Next earnings
2026-08-06
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 47,198,000 37,407,000 -17,167,000 -17,961,000 184,102,000 9,544,000 106,911,000
Dec 2025 62,519,000 50,401,000 -5,922,000 -9,394,000 190,581,000 10,708,000 103,249,000
Sep 2025 50,214,000 39,706,000 -15,676,000 -16,288,000 196,591,000 7,686,000 107,404,000
Jun 2025 47,387,000 37,752,000 -16,974,000 -17,398,000 206,443,000 8,052,000 108,828,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-15,970,000
Investing CF
$13,251,000
Financing CF
$2,077,000
CapEx
$-13,517,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.94
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-248,992,000
Inventory
$36,031,000
Receivables
$42,155,000
ST Investments
$37,659,000
EBIT TTM
$-53,682,000
Pretax Income TTM
$-59,002,000
Interest Exp TTM
$5,320,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$207,318,000
EBITDA
$-47,678,000
Free Cash Flow
$-5,769,750
Enterprise Value
$283,134,272
Total Cash
$51,854,000
Total Debt
$71,604,000
Shares Out
64,872,976
Trailing EPS
$-0.96
Book Value
$1.19
ROE
-66.9%
ROA
-17.9%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 212,690,000 -54,154,000 -59,002,000 190,581,000 103,249,000 -15,970,000
Dec 2024 209,357,000 -55,688,000 -55,743,000 217,094,000 104,202,000 -37,167,000
Dec 2023 187,118,000 -51,428,000 -49,527,000 251,907,000 113,969,000 -34,575,000
Dec 2022 141,838,000 -34,844,000 -42,815,000 159,024,000 98,495,000 -30,648,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.90

Max Pain — expiry 2026-09-18

max pain strike: $2.50 · spot: $3.92 · call oi: 1,803 · put oi: 21
Expected Move to 2026-09-18: ±$1.62 (41.45%) — implied range $2.30$5.55 · ATM straddle on $5.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
SGHT Sight Sciences, Inc. $279.12M $5.13
OBIO Orchestra BioMed Holdings, Inc. $245.51M $4.10
OSUR ORASURE TECHNOLOGIES INC $287.79M $4.18
PROF Profound Medical Corp. $240.74M $6.62
TLSI TriSalus Life Sciences, Inc. $231.54M $3.77

News headlines (Yahoo Finance, 1h cache)

Treace to Present at the Sidoti Small Cap Conference
2026-06-11 20:05 · Yahoo
June 2026's Top Penny Stocks To Watch
2026-06-11 12:05 · Yahoo
Treace Medical (TMCI) Q4 2025 Earnings Transcript
2026-06-01 17:35 · Yahoo
Treace Medical (TMCI) Q1 2026 Earnings Transcript
2026-06-01 17:34 · Yahoo
Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks
2026-05-13 12:05 · Yahoo
Treace Medical Concepts Inc (TMCI) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
2026-05-09 07:02 · Yahoo
Treace Medical Concepts Q1 Earnings Call Highlights
2026-05-09 04:07 · Yahoo
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates
2026-05-08 12:25 · Yahoo
Treace Medical Concepts Reports First Quarter 2026 Financial Results
2026-05-08 11:05 · Yahoo
How The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst Expectations
2026-05-03 08:06 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-06-12 9:26:46 2026-06-10 Treace John T. CEO, 10% P - Purchase 4.03 24606 99196
2026-06-11 16:52:42 2026-06-10 Treace John T. CEO, 10% P - Purchase 4.03 52317 210968